Buy Metronidazole and Treat Bacterial Issues

Bacterial infections and diseases can be gotten nearly everywhere.  There is really no way of telling when you can get an infection.  The best way in avoiding getting infected is by practicing proper sanitation and hygiene as well as having a healthy immune system.  Still, this is just to prevent usual infections from developing.  If you do get infected, you need to use antibiotics to properly eliminate the infection out of your system.  Buy metronidazole as this is considered by many as one of the most effective antibiotic drugs in the market today.

If you buy metronidazole, you are assured that you will be able to treat the bacterial infection you have developed.  However, you cannot buy metronidazole over-the-counter because you need a medical prescription to buy metronidazole.  Without any medical prescription, the pharmacist will not dispense and allow you to buy metronidazole.  These days, antibiotics have strictly become prescription drugs only due to the abuse that some people have done.  This is why if you were to have any type of bacterial disease, your only option in being able to buy metronidazole is to visit your doctor and have your issue diagnosed.  If your doctor believes you need to buy metronidazole as antibiotic treatment, you will be given prescription to buy metronidazole.

There are two ways to buy metronidazole.  You can buy metronidazole at your local pharmacy or you can buy metronidazole online.  A lot of people actually buy metronidazole online these days as they are able to get lots of savings.  The prices of metronidazole at online shops simply cannot be matched by a physical shop since online shops do not have to pay a lot of dues and permits just to be able to sell.  The low price of metronidazole is actually what draws most people who need to use metronidazole to buy metronidazole online. Read more…

The future of statin therapy

Use in normal-cholesterol patients is on the horizon — will over-the-counter be next?

The most frequently prescribed drug class in Canada may soon become much, much more popular.

AstraZeneca has filed an application with Health Canada to add a new indication for its drug rosuvastatin (Crestor). The application, filed late last year and still under review, asks that rosuvastatin be licensed for use in older patients with normal cholesterol levels but elevated high-sensitivity C-reactive protein (CRP). If approved, the new indication could potentially result in millions of Canadian patients being put on preventive statin therapy.

Whether or not AstraZeneca’s new application is approved, however, recent research makes it all but certain that statins are well on their way to far wider use in the years to come.

to read the rest of this article on the Parkhurst Exchange website.

Photo: Shutterstock

WHO growth charts replace US charts as gold standard

The way we keep track of kids' height and weight is changing.

The Canadian Paediatic Society and the College of Family Physicians of Canada have signed on to a new policy statement (PDF) endorsing the WHO's revised growth charts rather than the American CDC growth charts that have long been in use in this country. The new policy is also published in the February issue of the journal Paediatrics & Child Health.

On the Canadian Paediatric Society's website you can find more information, including a health professional's guide to using the WHO growth charts, a fact sheet for parents, and (soon) copies of the WHO charts specifically designed for Canadian doctors.

What was wrong with the CDC growth charts? Basically, they were outdated: their data were based on the assumption that most babies are fed formula, which may have been true 40 years ago but is not today. In a May 2009 column in Parkhurst Exchange magazine, Dr Richard Haber, an associate professor of pediatrics at McGill University and the Director of the Pediatric Consultation Centre at the Montreal Children’s Hospital, explained the CDC charts' problems:

"The revised [CDC] charts don’t necessarily represent optimal growth in infancy as the population data sets represent periods when most babies were bottle-fed; since 1970, only about 50% of infants were breastfed and of these merely 30% for greater than three months. What’s important to remember is that exclusively breastfed babies will plot higher for their weight in the first 6 months and lower for weight in the 6-12 month period. So they may appear to ‘fall off’ their curve. One other disadvantage is that the CDC curves represent cross-sectional data sets based on chronological age and not pubertal stage, and therefore don’t take into account the pubertal growth spurt."
Visit the PE website to read the rest of Dr Haber's May 2009 column, "," and its June 2009 follow-up on spotting red flags in growth data, "."

Image: